A guilty plea by a drug company

A $35 million settlement and a guilty plea by a drug company that allegedly misled patients and physicians about the intended uses of a drug designed to treat patients with a rare disorder that negatively impacted their cholesterol levels.

Logo icon
Logo icon
Logo icon
Logo icon
Logo icon
Logo icon
Logo icon